Colo-rectal cancer is the most common malignancy of the gastrointestinal tract and is the third frequency for malignancy in humans. CT and MRI development allows an early diagnosis and a modulation of the therapeutic approach. Many papers seem to confirm the role of PET/CT and virtual colonography in the evaluation of primary lesions. The PET/CT appears mode accurate in assessing lymph node metastases. Today, new approaches such as virtual colonoscopy and PET/CT open new horizons in the diagnosis and staging of cancer of the colon and rectum.

Virtual colonoscopy and PET/CT for diagnosis and staging of colorectal cancer

Genovese, Eugenio Annibale
2013-01-01

Abstract

Colo-rectal cancer is the most common malignancy of the gastrointestinal tract and is the third frequency for malignancy in humans. CT and MRI development allows an early diagnosis and a modulation of the therapeutic approach. Many papers seem to confirm the role of PET/CT and virtual colonography in the evaluation of primary lesions. The PET/CT appears mode accurate in assessing lymph node metastases. Today, new approaches such as virtual colonoscopy and PET/CT open new horizons in the diagnosis and staging of cancer of the colon and rectum.
2013
Adenocarcinoma; Colonography, Computed Tomographic; Colorectal Neoplasms; Diagnosis, Differential; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity; Ultrasonography
Rossi, Michele; Mallardo, Vania; Rosati, Immacolata; Prisco, Maria Rosaria; Califano, Teresa; Della Vecchia, Nicoletta; Romano, Giovanna; Di Lanno, Im...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2094740
 Attenzione

L'Ateneo sottopone a validazione solo i file PDF allegati

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact